Clinical Trials · NCT07117240
Evaluation of the Efficacy and Safety of GLP-1 Receptor Agonist Therapy In Steroid-Induced Diabetes
- Phase
- Phase 4
- Recruitment status
- Enrolling By Invitation
- Sponsor
- Medical University of Warsaw
- Enrollment
- 100
- Start date
- Jul 2025
- Locations
- 1 site, Poland
- Primary endpoint
- Glucose monitoring index and Time in range